Messenger Ribonucleic Acid Quality Monitoring Market Report 2026

Messenger Ribonucleic Acid Quality Monitoring Market Overview

• Messenger Ribonucleic Acid Quality Monitoring market size has reached to $1.47 billion in 2025 • Expected to grow to $2.49 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: The Rise In Demand For Personalized Medicines Is Driving The Growth Of The Market Due To Increasing Prevalence Of Chronic And Rare Diseases • Market Trend: New Benchtop Method Speeds Up Messenger Ribonucleic Acid Integrity And Cap Efficiency Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Messenger Ribonucleic Acid Quality Monitoring Market?

Messenger ribonucleic acid (mRNA) quality monitoring refers to the systematic assessment of the integrity, purity, and stability of mRNA molecules used in research, diagnostics, or therapeutics. This process ensures that the mRNA is free from degradation, contaminants, or structural abnormalities, which is critical for reliable experimental outcomes and safe, effective mRNA-based treatments. The main types of messenger ribonucleic acid (mRNA) quality monitoring are analytical instruments, reagents and consumables, and software and services. Analytical instruments are specialized laboratory devices designed to assess and ensure the integrity, purity, and critical quality attributes of mRNA molecules during research, development, and production processes. The technologies used include liquid chromatography-mass spectrometry (LC-MS), electrophoresis, enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR) techniques, and other technologies. These are used in various applications, such as vaccine development, therapeutic messenger ribonucleic acid products, and gene editing, and cater to various end users, including biopharmaceutical and biotechnology companies, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs) and analytical labs, and academic and research institutes or centers.

What Is The Messenger Ribonucleic Acid Quality Monitoring Market Growth Forecast?

The messenger ribonucleic acid quality monitoring market size is expected to see rapid growth in the next few years. It will grow to $2.49 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to expansion of therapeutic mrna pipelines, increasing regulatory scrutiny of mrna products, growing investment in biopharmaceutical manufacturing, rising adoption of real-time quality analytics, expansion of contract research and manufacturing services. Major trends in the forecast period include increasing adoption of standardized mrna quality control protocols, rising use of advanced analytical instrumentation, growing integration of automated quality monitoring systems, expansion of regulatory compliance testing, enhanced focus on mrna stability and integrity.

Global Messenger Ribonucleic Acid Quality Monitoring Market Segmentation

1) By Type: Analytical Instruments, Reagents And Consumables, Software And Services 2) By Technology: Liquid Chromatography-Mass Spectrometry (LC-MS), Electrophoresis, Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Techniques, Other Technologies 3) By Application: Vaccine Development, Therapeutic Messenger Ribonucleic Acid Products, Gene Editing 4) By End User: Biopharmaceutical And Biotechnology Companies, Contract Development And Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs) And Analytical Labs, Academic And Research Institutes Or Centers Subsegments: 1) By Analytical Instruments: Benchtop Analyzers, Microfluidic Systems, Spectrophotometers, Capillary Electrophoresis Systems 2) By Reagents And Consumables: Ribonucleic Acid Extraction Kits, Complementary Deoxyribonucleic Acid Synthesis Kits, Fluorescent Probes, Quality Control Standards 3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems, Consulting Services, Validation And Training Services

What Is The Driver Of The Messenger Ribonucleic Acid Quality Monitoring Market?

The increasing demand for personalized medicines is expected to propel the growth of the messenger ribonucleic acid quality monitoring market going forward. Personalized medicines refer to medical treatments that are tailored to an individual’s genetic makeup, lifestyle, and environment to ensure the most effective therapy for that specific patient. The increasing demand for personalized medicines is due to the rising prevalence of chronic and rare diseases, which necessitate targeted, patient-specific therapies for more effective treatment outcomes. Messenger ribonucleic acid quality monitoring ensures the accuracy, stability, and efficacy of mRNA-based therapies, directly supporting the development of safe and effective personalized medicines. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, marking a substantial rise from the six approvals recorded in 2022. Therefore, increasing demand for personalized medicines is driving the growth of the messenger ribonucleic acid quality monitoring industry.

Key Players In The Global Messenger Ribonucleic Acid Quality Monitoring Market

Major companies operating in the messenger ribonucleic acid quality monitoring market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Intertek Group plc, Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., WuXi Biologics (Cayman) Inc., QIAGEN N.V., Bio-Techne Corporation, Fujifilm Diosynth Biotechnologies, GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies Ltd., Creative Biolabs Inc., Creative Diagnostics, Jena Bioscience GmbH.

Global Messenger Ribonucleic Acid Quality Monitoring Market Trends and Insights

Major companies operating in the messenger ribonucleic acid quality monitoring are focusing on developing innovative solutions, such as benchtop instruments, for rapid and accurate assessment of messenger ribonucleic acid quality attributes. A benchtop instrument is a compact laboratory device designed to perform specialized analyses or experiments on a laboratory bench, offering convenience, speed, and accessibility without the need for large-scale equipment. For instance, in June 2024, InDevR Inc., a US-based biotechnology and analytical instrumentation company, launched 5’CapQ, a rapid benchtop assay for assessing critical quality attributes (CQAs) of mRNA-based vaccines. The assay measures both the integrity and 5’ capping efficiency of mRNA molecules in under two hours, combining these key quality metrics into a single streamlined test. It works by selectively capturing mRNA molecules with a 5’ cap and fluorescently labeling the poly(A) tail, ensuring that only fully intact, capped mRNA essential for stability and protein translation is quantified. By providing fast, quantitative, and easy-to-use analysis, 5’CapQ helps eliminate testing bottlenecks in mRNA vaccine development without requiring specialized expertise or lengthy processing times.

What Are Latest Mergers And Acquisitions In The Messenger Ribonucleic Acid Quality Monitoring Market?

In September 2024, Agilent Technologies Inc., a US-based technology and life sciences company, acquired BIOVECTRA Inc. for an undisclosed amount. With this acquisition, Agilent aims to enhance its biopharma services footprint by adding contract development and manufacturing capabilities for biologics and advanced therapies. Biovectra Inc. is a Canada-based company that provides messenger ribonucleic acid (mRNA) quality monitoring.

Regional Insights

North America was the largest region in the messenger ribonucleic acid quality monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Messenger Ribonucleic Acid Quality Monitoring Market?

The messenger ribonucleic acid (mRNA) quality monitoring market consists of revenues earned by entities by providing services such as purity and contaminant testing, potency and functionality assays, stability and storage monitoring, analytical method development and validation, endotoxin testing, and capping efficiency analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The messenger ribonucleic acid (mRNA) quality monitoring market also includes sales of quantification kits, reference materials, detection devices, microfluidic platforms, and analytical software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Messenger Ribonucleic Acid Quality Monitoring Market Report 2026?

The messenger ribonucleic acid quality monitoring market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the messenger ribonucleic acid quality monitoring industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.